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Abstract
Introduction: On March 6, 2020, the current ongoing pandemic of severe acute respiratory 
syndrome coronavirus 2 (SARS-CoV-2) also known as COVID-19 reached the commonwealth 
of Kentucky. Within days the first cases of infection and hospitalization were identified among 
healthcare workers (HCW) in Kentucky, other states in the U.S., and around the world. There 
is little information available regarding the impact of COVID-19 on the HCW population within 
this area. The objective of this study is to describe the baseline characteristics of hospitalized 
HCWs infected with COVID-19.
Methods: Data collection was performed as part of a retrospective study of patients hospital-
ized with COVID-19 in any of nine acute care hospitals in Louisville. COVID-19 infection was 
confirmed using Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR). Descriptive 
statistics were performed on clinical and epidemiological characteristics of hospitalized patients 
with COVID-19 who had indicated healthcare as their occupation.
Results: Of the 700 adults hospitalized with COVID-19 from March 7 through July 1, 2020, 23 
were HCWs. The mean age was 51 years and 78% were female. The majority of hospitalized 
HCWs had comorbidities including obesity (70%), hypertension (57%), hyperlipidemia (35%) 
and diabetes (26%). Common symptoms reported were fever (70%), dyspnea (78%), cough 
(78%) and fatigue (57%). Nine HCWs (39%) were admitted to the intensive care unit (ICU) and 
6 (26%) developed acute respiratory distress syndrome (ARDS). Two (9%) patients developed 
a new, serious arrhythmia, two sustained cardiac arrest (9%), and two (9%) died in-hospital.
Conclusions: Older adult HCWs with underlying health conditions such as obesity and hy-
pertension were more likely to be hospitalized and have severe in-hospital complications. One 
HCW death due to COVID-19 was identified in this small population. These findings can help to 
identify and strengthen approaches to protect HCWs from SARS-CoV-2 infection and from long 
term effects of COVID-19. 
Introduction
As of August 29, 2020, the World Health Organization (WHO) has reported over 24.5 
million cases of COVID-19 with close to 850,000 deaths. [1] Many initial studies have 
shown disproportionate rates of infection among healthcare workers (HCWs). [2-9] One 
early study in Wuhan, China described the clinical characteristics of cases of COVID-19 
among HCWs who provided care for patients with known or suspected disease. They 
found that among 138 hospitalized patients, 40(29%) were HCWs that were suspected of 
hospital-associated transmission. [3] 
A recent CDC study found that among COVID-19 cases reported between February 12 
through April 9, 2020, 19% were identified as HCWs. The study also found that 38% of 
the cases reported at least one underlying health condition and the majority of infected 
HCWs were not hospitalized (90%); however, 184 (2%–5%) HCWs were admitted to the 
Intensive Care Unit (ICU) with 27 (0.3%–0.6%) deaths. Common symptoms recognized 
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among infected HCWs included fever, cough, shortness of breath, muscle aches and headaches. Among the cases who 
reported exposure information, 55% stated their only contact was in a healthcare setting within the 14 days before their 
illness onset. [10] As of August 29, CDC has reported close to 700 deaths among HCWs with a caveat recognizing that 
these data likely fail to capture the true rate of mortality due to COVID-19 in this group. [11]
Protecting HCWs from transmissible infection and recognizing when exposure may have occurred have long been 
recognized as vital components in routine infection prevention and control practice in all settings where healthcare is 
delivered. These factors stress the importance of studying HCWs as a means of determining effective local policy and 
strategies that protect this vital infrastructure. The objective of this paper is to describe the characteristics of hospital-
ized HCWs diagnosed with COVID-19 illness admitted to one of the nine adult hospitals in Louisville, Kentucky from 
March through July 2020.  
Methods
Study design  
The Center of Excellence for Research in Infectious Diseases (CERID) at the University of Louisville maintains an 
ongoing retrospective cohort study of hospitalized patients infected with SARS CoV-2 to determine the burden of 
COVID-19 in the Louisville, Kentucky area. The main objective of this study was to explore the incidence, epidemiol-
ogy, demographics, clinical characteristics and outcomes of hospitalized patients diagnosed with COVID-19 admitted 
during the first four months of the pandemic (March-July 2020) in Louisville.  
Human Subjects Protection
The University of Louisville Institutional Review Board approved the Burden of COVID-19 study (IRB #20.0257), as 
well as the research offices at each participating hospital. The study was exempt from informed consent. Study data 
were collected and managed using HIPAA-compliant electronic capture data tools hosted at the University of Louis-
ville. REDCap (Research Electronic Data Capture) is a secure, web-based software platform designed to support re-
search studies. [12] All information is considered protected health information and standard data safety processes were 
followed.
Study Setting and Subjects
The Burden of COVID-19 study included nine acute care hospitals in Louisville, Kentucky. The inclusion criteria were 
to have either evidence of a positive Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) on the first or the 
repeat test and/or presentation of ground glass opacities on a chest computerized tomography (CT), including date 
of tests. Patients who were not hospitalized/admitted to the any of the nine hospitals were excluded (e.g., seen in an 
Emergency Department and discharged). A total of 700 adults were hospitalized between March 7-July 1, 2020 and 
captured for the Burden of COVID-19 study. A healthcare worker was defined in the Burden of COVID-19 study as hav-
ing documentation of current occupation as a healthcare worker in their medical record.
Data Collection
The RT-PCR testing was performed either by the University of Louisville Division of Infectious Diseases reference 
laboratory or at each respective hospital’s associated lab, with standard of care testing. Patients with a confirmed or 
suspected positive COVID-19 diagnosis were ascertained either through daily screenings of the hospital’s Electronic 
Medical Record (EMR) by the CERID research team or from a daily report sent by the hospital. Information collected 
included COVID-19 test results, demographic and hospitalization data, past medical and social history, current medi-
cations, signs and symptoms, physical examination, laboratory, radiologic and microbiologic findings, management and 
therapies, in-hospital complications and clinical outcomes. 
Statistical Analysis 
Descriptive statistics were performed on relevant variables stratified by healthcare worker status, which was catego-
rized dichotomously (yes/no). Continuous data are presented as mean ± standard deviation (SD), if normally distrib-
uted or as median (interquartile range (IQR), Q1-Q3), if not normally distributed. Categorical data are presented as 
percentage (%), when appropriate. All statistical analyses were performed using R version 3.6.3 and R Studio version 
1.2.5033 (Boston, MA, USA).
Results
Among the 700 adults hospitalized with COVID-19, 23 (3%) met the healthcare worker definition and were hospital-
ized from March 9 through June 20, 2020. All 23 hospitalized HCWs were confirmed COVID-19 positive by RT-PCR 
with 10 also positive for ground glass opacities on CT exam. The mean age of hospitalized HCWs was 51 years (SD= 
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Characteristics
No. 23
Age (years), mean ± SD 51 ± 14.2
Age (years), %
     ≤35 5(21.7)
     36-55 9(39.1)
56-64 6(26.1)
 ≥65 3(13.0)
Body Mass Index (kg/m2), mean ± SD 35.0 ± 8.8
Body Mass Index (kg/m2),%
     Underweight (<18.50 kg/m2) 0(0.0)
     Normal (18.50-24.99 kg/m2) 3(13.0)
     Overweight (25.00-29.99 kg/m2) 4(17.4)
     Obese (>30.00 kg/m2) 16(69.6)
Sex (%)
     Female 18(78.3)
     Male 5(21.7)
Race (%)
     Black 8(34.8)
     White 13(56.5)
     Unknown 2(8.7)
Ethnicity (%)
     Hispanic 0(0.0)
     Non-Hispanic 21(91.3)
     Unknown 2(8.7)
Recent contact with another person with 
respiratory symptoms 12(52.2)
Table 1. Demographic characteristics of healthcare workers 
hospitalized with COVID-19 (N=23)
14.2) (Figure 1), mean body mass index (BMI) was 35 kg/m2 (SD= 8.8), 18 (78%) were females and 13 (57%) were of 
Caucasian race (Table 1). The majority of HCWs reported having at least one symptom; 18 (78.0%) reported dyspnea, 18 
(78%) reported cough, 16 (70%) reported a fever and 13 (57%) reported fatigue. Less common symptoms included my-
algia, headache, cough with sputum, sore throat, dizziness and diarrhea (Table 2). The median duration from symptom 
onset to hospitalization was 4 days (IQR, 3.0-7.8). Physical examination findings within the first 24 hours of admission 
were within normal ranges except for minor deviations in heart rate and oxygen saturation levels (Table 2). Laboratory 
results were also within normal ranges (Table 2). 
All 23 hospitalized HCWs had at least one underlying health condition. Obesity (16 [70%]), hypertension (13[57%]), hy-
perlipidemia (8[35%]), diabetes (6[26%]) and asthma (5[22%]) were the more common comorbidities (Figure 2). A to-
tal of nine HCWs were admitted to the ICU, with two of nine patients having two ICU admits. Most of the hospitalized 
HCWs received antibiotic therapy as a form of treatment (azithromycin; 15[65%] and hydroxychloroquine; 8[35%]). 
Of the 23 patients, 13 (57%) received high flow nasal cannula, 4 (17%) received vasopressors, 7 (30%) received inhaled 
pulmonary vasodilators (IPV) and 4 (17%) patients received noninvasive mechanical ventilation (NIMV) (Table 3). In 
the ICU, 6 (26%) required invasive mechanical ventilation (IMV) during the hospitalization (Table 3). The two most 
common in-hospital complications included acute respiratory distress syndrome (ARDS) (6[26%]) and septic shock 
(3[13%]). Two (9%) of the 9 ICU patients developed a new, serious arrhythmia, two sustained cardiac arrest (9%), and 
two (9%) died in-hospital.
Percentages may not total 100 due to rounding.
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Figure 1. Distribution of ages among healthcare workers infected with 
COVID-19 hospitalized between March 9 – June 20, 2020 in Louisville, 
Kentucky (N=23)
Signs and Symptoms N (%)
Fever 16(69.6)
Dyspnea 18(78.3)
Cough 18(78.3)
Sputum 4(17.4)
Myalgia 10(43.5)
Fatigue 13(56.5)
Headache 2(8.7)
Time from illness onset to admission (days), median (Q1-
Q3) N=22 4.0(3.0-7.8)
Physical Examination
(within first 24 hours of hospital admission)
Heart rate (beats/minute), mean ± SD 98.4 ± 18.7
Respiratory rate (breaths/minute), median(Q1-Q3) 20.0(18.0-23.5)
Systolic blood pressure (mmHg), mean ± SD 123.0 ± 20.3
Diastolic blood pressure (mmHg), mean ± SD 65.7 ± 10.8
Temperature (degrees Celsius), median(Q1-Q3) 38.1(37.1-39.3)
O2 saturation,(%) median(Q1-Q3) N=22 94.5(92.3-97.0)
FiO2, median(Q1-Q3) N=20 21.0(21.0-24.5)
Altered mental status (%) 1(4.4)
Laboratory Findings
Hemoglobin (mg/dL), mean ± SD 13.1± 1.8
White Blood Count, (x 1000 per µL), median(Q1-Q3) 5.8(4.8-7.6)
Platelet count (x 1000 per µL), mean ± SD 195.1± 61.3
Neutrophil count (x 1000 per µL), median(Q1-Q3) 3.8(3.3-6.3)
Lymphocyte count (x 1000 per µL), median(Q1-Q3) 1.1(0.9-1.6)
C -reactive protein, (mg/L)), median(Q1-Q3), N=13 8.8(2.7-27.0)
Serum bicarbonate (mEq/L), median(Q1-Q3), N=22 24.0(22.0-27.4)
Procalcitonin (< 0.05 µg/L), median(Q1-Q3), N=16 0.05(0.05-0.09)
Percentages may not total 100 due to rounding.
Table 2. Signs, symptoms physical and laboratory findings of healthcare 
workers hospitalized with COVID-19 (N=23) 
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Figure 2. Comorbidities of healthcare workers hospitalized with 
COVID-19 (N=23)
Treatment in Hospital N (%)
Hydroxychloroquine 8(34.8)
Azithromycin 15(65.2)
Remdesivir 2(8.7)
High Flow Nasal Cannula 13(56.5)
Continuous Positive Airway Pressure (CPAP) 2(8.7)
Non-Invasive Mechanical Ventilation 4(17.4)
Invasive Mechanical Ventilation 6(26.1)
Proning Position 5(21.7)
Plasma Therapy 3(13.0)
Neuromuscular blockade/Artificial paralysis 5(21.7)
Inhaled pulmonary vasodilators 7(30.4)
Vasopressors 4(17.4)
Inotropes 1(4.4)
In-hospital complications 
Acute Respiratory Disease Syndrome 6(26.1)
Septic Shock 3(13.0)
Development of Heart Failure 0(0.0)
Sustained cardiac arrest 2(8.7)
Development of acute myocardial infarction 0(0.0)
Pulmonary edema 0(0.0)
Pulmonary embolism 0(0.0)
Development of new, serious arrhythmia 2(8.7)
Cerebrovascular accident 0(0.0)
Mortality 2(8.7)
Table 3. Treatments and complications of healhcare workers hospitalized 
with COVID-19 (N=23)
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Mortality Profile
There were two documented deaths among the 23 hospitalized HCWs. One patient was a 52-year-old, African Ameri-
can female, who tested positive for COVID-19 by RT-PCR on the day of admission. Her symptoms started 4 days before 
admission and included fever, productive cough, dyspnea, nausea and fatigue. She had a past medical history of dia-
betes and hypertension and was on ace inhibitors, angiotensin receptor blockers, metformin and prednisone at home. 
On admission, she was tachycardic, tachypneic, slightly hypoxic, documented as altered mental status and had diffuse 
bilateral infiltrates on both chest x-ray and CT. She was directly admitted to the ICU, where she was treated with azi-
thromycin for 2 days, received high flow nasal cannula, CPAP, IPV and vasopressors. For one day, she was placed on 
NIMV but later required IMV. Over the 7-day ICU course, the patient went into septic shock, developed ARDS and a 
new, serious arrythmia and ultimately sustained cardiac arrest which led to her death.
The second patient was a 34-year-old, African American male HCW with an advanced directive. His symptoms started 
2 days prior to hospitalization and included fatigue, cough and dyspnea. He was a current smoker, had a past medical 
history of alcohol abuse and asthma and was on a bronchodilator and anti-epileptic medications. On admission, he was 
slight tachypneic and hypoxic and had diffuse bilateral infiltrates on both chest x-ray and CT. Initial labs showed ele-
vated white blood cell count, neutrophil count, bilirubin and liver function test. The patient was transferred to the ICU 
on the third day of admission, where he tested positive for COVID-19 by RT-PCR and was treated with azithromycin 
and cefepime. He also received plasma therapy, high flow nasal cannula, neuromuscular blockades, IPV, vasopressors 
and inotropes. Over his 18-day ICU stay, the patient was also diagnosed with Methicillin-resistant Staphylococcus Au-
reus and was placed on systemic steroids. He shortly after developed ARDS requiring IMV, which he was on for 16 days 
until his death.
Discussion
This study provides the first overview of the impact of COVID-19 on healthcare workers in the Louisville, Kentucky 
area. From March 6 through July 1, 2020, 23 HCWs were hospitalized with COVID-19 with two documented deaths 
from COVID-19 pneumonia. 
Overall, this hospitalized HCW population was older with higher rates of comorbidities, unlike a recent CDC report 
analyzing national data of HCWs infected with COVID-19. The mean age in this study was 51 years (SD=14.2 years) com-
pared to a median of 42 years (IQR = 32–54 years) in a recent CDC report. [10] All hospitalized HCWs with COVID-19 
in this study had at least one underlying health condition compared to 38% and 35% in other studies. [10,13] One study 
showed significant increases in obesity prevalence among healthcare workers from 2004 through 2011. [14] However, 
the comorbidities among the HCWs in this study such as obesity, hypertension, diabetes and asthma were consistent 
with state-level rates. [10,13] Female HCWs (18 [78%]) were more likely to be hospitalized compared to males which 
was also consistent with several studies. [8-10,13,15] Common symptoms including fever, cough, dyspnea, fatigue and 
myalgia were seen in U.S. analyses of HCWs with COVID-19. [10,15,16,17] While there was a lower percentage of hos-
pitalized HCWs in our study, there was a higher percentage of in-hospital complications and death compared to other 
studies. [9,10,15] There was also a higher percentage of hospitalized HCWs admitted to the ICU, as well as HCWs with 
ARDS and septic shock. [9,10,15] Treatments such as hydroxychloroquine and azithromycin given to the HCWs in this 
study reflected the state of knowledge at the time and are no longer standard of care. One randomized controlled trial 
showed that using hydroxychloroquine with or without azithromycin on patients hospitalized with COVID-19 did not 
improve their 15-day clinical status compared to standard care. [18] The standard care included the use of antibiotics, 
anti-viral agents, glucocorticoids and others, at the discretion of the physician. [18] 
Kentucky’s first COVID-19 case was confirmed on March 6, 2020 and a state of emergency was declared. Local testing 
through the University of Louisville was readily available and allowed for rapid testing. The baseline characteristics 
of HCWs hospitalized with COVID-19 can help to inform healthcare policies regarding infection control including 
personal protective equipment (PPE). One recent rapid review of eleven articles found that work overload, underly-
ing comorbidities, lack of PPE, exposure to infected patients and poor infection control were the main risk factors of 
COVID-19 infection among HCWs. [19] These risk factors along with the atypical clinical manifestations of COVID-19 
and asymptomatic but infectious cases may not have been recognized in the early phase of the pandemic leading to 
higher rates of severe COVID-19 cases among HCWs. 
There are a few limitations to acknowledge. The results of this retrospective study may not be generalizable to all 
HCWs or the public as they may be significantly different from HCWs hospitalized with COVID-19. Due to the nature 
of this retrospective, observational study, we were not able to collect more detailed information on the classification of 
healthcare workers and exposures or causes of COVID-19 infection. The healthcare worker definition was self-report-
ed and may not have included all personnel who work in a healthcare setting that have direct or indirect exposure to 
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COVID-19 patients limiting the sample size to 21. The small sample size of HCWs hospitalized with COVID-19 may re-
flect the availability of PPE and effective infection control processes or it may reflect more asymptomatic cases among 
HCWs. Future research should consider using prospective studies to follow healthy, uninfected HCWs to COVID-19 
infection, so as to fully understand transmission modes, risk factors and biological mechanisms. 
The current, ongoing COVID-19 pandemic remains a growing public health problem, putting frontline HCWs at the 
highest risk of infection. This retrospective analysis describes the characteristics of HCWs hospitalized with COVID-19 
from March 9 through June 20, 2020 in Louisville, Kentucky. These findings suggest that older, obese HCWs with un-
derlying comorbidities may be more likely to be hospitalized with severe COVID-19 infection. Further, the long-term 
impacts of COVID-19 and their relevance to the ability and willingness of the HCW to return to work should be part of 
ongoing research.  
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